Third Amendment to Pooled Patents Agreement

CONFIDENTIAL TREATMENT REQUESTED

CERTAIN INFORMATION OMITTED AND FILED SEPARATELY WITH THE SEC

Third Amendment to Pooled Patents Agreement

This Third Amendment to the Pooled Patents Agreement (the “Third Amendment”) is effective as of the date of last signature found below (“Third Amendment Effective Date”) between Illumina, Inc., a Delaware corporation having a place of business at 0000 Xxxxxxxx Xxx, Xxx Xxxxx, XX 00000 ("Illumina") and Sequenom, Inc., a Delaware corporation, having a place of business at 0000 Xxxx Xxxxxxx Xxxxx, Xxx Xxxxx XX 00000 (“Sequenom”). Sequenom and Illumina may be referred to herein as “Party” or “Parties.”

WHEREAS, the Parties entered into the Pooled Patents Agreement, dated December 2, 2014, as amended via a First Amendment dated April 21, 2016 and via a Second Amendment dated April 17, 2017 (“Agreement”);

WHEREAS, the Parties desire to amend Schedule 1A of the Agreement to permit lower Test Fees to be paid by certain additional companies, as identified herein; and

WHEREAS, for good and valuable consideration, the Parties agree to amend the Agreement as follows:

1. Schedule 1A is amended to add the following entities:

[…***…]

Except as expressly modified herein, the Agreement shall remain in full force and effect in accordance with its terms. All capitalized terms not defined in this Third Amendment shall have the meaning ascribed to them in the Agreement.

IN WITNESS WHEREOF, the Parties have signed this Third Amendment as of the dates indicated below.

ILLUMINA			SEQUENOM
By:	/s/ Xxxx Xxxxx		By:	/s/ Xxxx Xxxxxxxx
Name:	Xxxx Xxxxx		Name:	Xxxx Xxxxxxxx
Title:	VP, Corporate & Business Development		Title:	SVP, LabCorp.
Date:	August 21, 2017		Date:	August 28, 2017